PhD in Neuroscience - Neuropharmaceutics and Neuro-oncology in Minneapolis United States | University of Minnesota Twin Cities

Neuro-pharmaceutics centers on pinpointing therapeutic targets and transforming these findings into innovative drugs and treatments. Our neuro-oncology research similarly emphasizes neuropharmaceutical strategies, addressing both the demand for neuroactive compounds and enhanced brain delivery techniques. A dedicated team from the Graduate Program in Neuroscience collaborates extensively with faculty at the University of Minnesota's Masonic Cancer Center, investigating the CNS's distinctive features like the blood-brain barrier.

Neuropharmaceutics research encompasses: epilepsy drug discovery to reduce seizure activity, transport proteins regulating drug distribution, spinal-administered pain relief for chronic conditions, psychiatric disorder medications, nasal delivery systems for Alzheimer's treatment, preclinical evaluation methods for neurodegenerative diseases, dementia prevention therapies, and chronic pain management solutions. Neuro-oncology studies involve: cancer gene identification through insertional mutagenesis, CNS tumor-targeting pharmaceuticals, vaccine effectiveness for inflammatory disorders, cancer pain management strategies, brain tumor gene therapies, and protein engineering to explore neuronal signaling for therapeutic potential.